Tissue Regenix Group plc reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was USD 14.1 million compared to USD 11.84 million a year ago. Net loss was USD 0.893 million compared to USD 1.6 million a year ago.

Basic loss per share from continuing operations was USD 0.0127 compared to USD 0.0228 a year ago.